This Week at the FDA: Opioid Crack and Orphan Drugs

Happy Halloween!

As the spookiest day of the year approaches, we’re highlighting FDA announcements from the last week and a half we think you should  hear about.

Check them out below!

STRO-001 Receives FDA’s Orphan Drug Status for Multiple Myeloma Treatment

A company developing a treatment for multiple myeloma just received food news,

FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs; including opioids

Obioid abuse has serious consequences, but many people with chronic pain depend on them for a good quality of life. This FDA crackdown is the newest step in the efforts to address this.

Experimental Alagille Syndrome Treatment Gets Orphan Drug Designation

Another rare disease win!


 

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email

What are your thoughts on being a rare disease advocate? Share your stories, thoughts, and hopes with the Patient Worthy community!

Close Menu